Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Published Date: 01 Mar 2023

Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland enlarges, causing problems or obstruction in urination...

Read Full News

Latest News

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Health news and commentary gathered by MedPage Today staff

FDA Approves Novel Treatment for UTIs

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Mission Health Urologists Disappear.

Following the takeover by HCA, experts identify the most recent departures.

More then ever, the healthcare industry needs qualified expert witnesses.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

The medication used to treat sexual desire disorder in women also helps men.

Melanoside is associated with several beneficial effects on male sexual function.

Combination Treatments for Erectile Dysfunction: Uneven Outcomes.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

Todays Updates

Nalbuphine Extended-Release Reduces Chronic Cough in IPF, with Philip Molyneaux, MBBS Philip Molyneaux, MBBS

New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease Marco Meglio

A phase 2 study at CTAD 2025 explores VHB937's potential in treating early Alzheimer disease, focusing on safety and efficacy in patients.

MRI Analysis Shows Stem Cell Therapy Laromestrocel Reduced Neuroinflammation in Mild Alzheimer Disease Isabella Ciccone, MPH

In an analysis of the phase 2a CLEAR MIND study presented at CTAD 2025, laromestrocel treatment was associated with reduced hippocampal neuroinflammation in patients with mild Alzheimer disease.

Phase 3 Trial to Uncover Therapeutic Potential of 5-HT6 Antagonist Masupirdine to Treat Alzheimer Agitation Louie Pasculli

A new phase 3 clinical trial is underway to evaluate masupirdine, a selective 5-HT6 receptor antagonist, as a potential treatment for agitation in patients with Alzheimer’s disease.

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

Todays Updates

Nalbuphine Extended-Release Reduces Chronic Cough in IPF, with Philip Molyneaux, MBBS Philip Molyneaux, MBBS

New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease Marco Meglio

A phase 2 study at CTAD 2025 explores VHB937's potential in treating early Alzheimer disease, focusing on safety and efficacy in patients.

MRI Analysis Shows Stem Cell Therapy Laromestrocel Reduced Neuroinflammation in Mild Alzheimer Disease Isabella Ciccone, MPH

In an analysis of the phase 2a CLEAR MIND study presented at CTAD 2025, laromestrocel treatment was associated with reduced hippocampal neuroinflammation in patients with mild Alzheimer disease.

Phase 3 Trial to Uncover Therapeutic Potential of 5-HT6 Antagonist Masupirdine to Treat Alzheimer Agitation Louie Pasculli

A new phase 3 clinical trial is underway to evaluate masupirdine, a selective 5-HT6 receptor antagonist, as a potential treatment for agitation in patients with Alzheimer’s disease.

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

Latest News

Health news and commentary gathered by MedPage Today staff

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Following the takeover by HCA, experts identify the most recent departures.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

Melanoside is associated with several beneficial effects on male sexual function.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

News All Time

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

The results of minimally invasive pyeloplasty (MIP) for the primary cause, ureteropelvic junction obstruction (UPJO), were examined in a recent study.

Medical Bulletin November 30, 2023.

The top medical stories of the day are as follows: ADHD increases the risk of car crashes in older adults. ADHD is a neurodevelopmental disorder that is chronic and has symptoms.

The only viable solution for stress urinary incontinence with mesh slings is informed decision-making.

UK: A recent study thoroughly examined the short- and long-term mesh sling complications reported in European Urology Focus.

Black people who consume a few servings of whole grains have been shown to experience a slower rate of memory loss.

A slower rate of memory loss may be experienced by Black individuals who consume more whole grain-containing foods, such as popcorn, quinoa, and some breads and cereals.

Wellness Bulletin 25/November/2023.

Here are the top health stories for the day:Doctors performing 'Two Finger Test' will be guilty of misconductReiterating the fact that the Supreme.

Do Patients Follow Up on Recommended Care Following Telehealth Visits?

Experts offer tips for improving compliance after telehealth visits. How many patients follow through on your recommendations after they've finished their visit? Does it matter whether you saw them virtually or in person?

Details of the MCC withdrawal of two MCh Urology seats from the Round 1 NEET SS Counseling Seat Matrix are provided.

New Delhi: MCH Urology's seats in Round 1 NEET have been withdrawn, as announced by the Medical Counselling Committee (MCC) in a recent notice.

Recommended News For You

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

Year in Review: Chronic Lymphocytic Leukemia

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

Loneliness and social isolation linked to heightened risk of death in those with cancer

A protein with new anticancer activity has been identified

Study shows virtual reality headsets may help ease cancer pain

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Recommended Articles For You

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis 

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases 

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders 

A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research discovery halts childhood brain tumor before it forms

2.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

3.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

4.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

5.

a cutting-edge cancer diagnostic tool.

1.

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care

2.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

3.

Liquid Biopsy: A Game-Changer in T-Cell Lymphoma Detection and Management

4.

The Genetics of Bernard Soulier Syndrome: What We Know so Far

5.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Navigating the Complexities of Ph Negative ALL - Part II

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot